Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Koscielny

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Current Opinion in Obstetrics & Gynecology|January 17, 2008
Critical review of microarray-based prognostic tests and trials in breast cancerSerge Koscielny
Science Translational Medicine|April 8, 2010
Why most gene expression signatures of tumors have not been useful in the clinicSerge Koscielny
Nature Reviews. Cancer|November 26, 2008
On clonogenic tumour cells and metastasis-forming cellsMaurice Tubiana, Serge Koscielny
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Clinical usefulness of microarrays for cancer prognosis in 2010--letterSerge Koscielny, Stefan Michiels
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2010
Loco-regional recurrence risk and post-mastectomy radiotherapy in breast cancerRodrigo Arriagada, Serge Koscielny
Nature Reviews. Cancer|January 23, 2010
Parallel progression of tumour and metastasesSerge Koscielny, Maurice Tubiana
European Journal of Cancer (Oxford, England : 1990)|September 15, 2014
Should we resist to including tumour growth patterns in Response Evaluation Criteria in Solid Tumours evaluation? (Response to Litière et al.)Loic Verlingue, Serge Koscielny, Charles Ferté
Molecular Oncology|February 26, 2011
Multidimensionality of microarrays: statistical challenges and (im)possible solutionsStefan Michiels, Andrew Kramar, Serge Koscielny
Lancet (London, England)|February 12, 2005
Prediction of cancer outcome with microarrays: a multiple random validation strategyStefan Michiels, Serge Koscielny, Catherine Hill
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
TGR analysis in phase I clinical trials--responseCharles Ferté, Serge Koscielny, Jean-Charles Soria
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Current Opinion in Obstetrics & Gynecology|January 17, 2008
Critical review of microarray-based prognostic tests and trials in breast cancerSerge Koscielny
Science Translational Medicine|April 8, 2010
Why most gene expression signatures of tumors have not been useful in the clinicSerge Koscielny
Nature Reviews. Cancer|November 26, 2008
On clonogenic tumour cells and metastasis-forming cellsMaurice Tubiana, Serge Koscielny
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Clinical usefulness of microarrays for cancer prognosis in 2010--letterSerge Koscielny, Stefan Michiels
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2010
Loco-regional recurrence risk and post-mastectomy radiotherapy in breast cancerRodrigo Arriagada, Serge Koscielny
Nature Reviews. Cancer|January 23, 2010
Parallel progression of tumour and metastasesSerge Koscielny, Maurice Tubiana
European Journal of Cancer (Oxford, England : 1990)|September 15, 2014
Should we resist to including tumour growth patterns in Response Evaluation Criteria in Solid Tumours evaluation? (Response to Litière et al.)Loic Verlingue, Serge Koscielny, Charles Ferté
Molecular Oncology|February 26, 2011
Multidimensionality of microarrays: statistical challenges and (im)possible solutionsStefan Michiels, Andrew Kramar, Serge Koscielny
Lancet (London, England)|February 12, 2005
Prediction of cancer outcome with microarrays: a multiple random validation strategyStefan Michiels, Serge Koscielny, Catherine Hill
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
TGR analysis in phase I clinical trials--responseCharles Ferté, Serge Koscielny, Jean-Charles Soria
Pageof 8